Neuroimaging Biomarker


Neuroimaging biomarker These biomarkers are quantifiable characteristics of biological processes related to Alzheimer's disease that are linked to clinical endpoints and thus can be used as surrogates for the disease process. Over the last decade, numerous advances have been made in developing biomarkers for AD using neuroimaging approaches. Neuroimaging is a branch of medical imaging that focuses on the brain. In addition to diagnosing disease and assessing brain health, neuroimaging also studies: How the brain works. How various activities impact the brain.Blood, urine, and cerebrospinal fluid provide the necessary biological information for the diagnosis. In these conditions, biomarkers are used as an indicator of a biological factor that represents either a subclinical manifestation, stage of the disorder, or a surrogate manifestation of the disease.


    Related Conference of Neuroimaging Biomarker

    March 14-15, 2024

    36th World Conference on Neurology

    Paris, France
    March 18-19, 2024

    28th International Conference on Neurology & Neurophysiology

    Zurich, Switzerland
    April 11-12, 2024

    36th World Neuroscience and Neurology Conferences

    Amsterdam, Netherlands
    April 11-12, 2024

    38th European Neurology Congress

    Amsterdam, Netherlands
    April 11-12, 2024

    36th World Congress on Neurorehabilitation

    Amsterdam, Netherlands
    May 30-31, 2024

    2nd International conference on Neuro Surgery

    Vienna, Austria
    June 13-14, 2024

    37th European Neurology Congress 2024

    Rome, Italy
    June 27-28, 2024

    6th World Depression Congress

    Paris, France
    June 27-28, 2024

    2nd International conference on Dementia

    London, UK
    July 11-12, 2024

    4th Annual Dementia Congress

    Vancouver, Canada
    July 15-16, 2024

    7th World Conference on Neuroscience

    London, UK
    August 13-14, 2024

    14th Global Alzheimers Summit

    Amsterdam, Netherlands
    August 16-17, 2024

    30th Annual Summit on Neuroscience & Neurological Disorders

    Melbourne, Australia
    October 31-01, 2024

    7th Global Congress on Spine and Spinal Disorders

    Amsterdam, Netherlands

    Neuroimaging Biomarker Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in